Our Company

Tandem Diabetes Care, Inc. is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells a family of insulin pump products, which includes the t:slim X2™ Insulin Pump, the next-generation color touchscreen pump, the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements, and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tandem Diabetes Care's financial performance into perspective.

Stock Quote
NASDAQ: TNDM
Price:
$2.20
Change:
+ 0.15
Day High:
2.34
Day Low:
2.05
Volume:
193,727
3:15 PM ET on Dec 5, 2016

View all »   RSSRecent Releases

Nov 29, 2016
Tandem Diabetes Care to Draw Down $35 Million under Existing Term Loan Facility with CRG

Nov 21, 2016
Tandem Diabetes Care to Present at the 28th Annual Piper Jaffray Healthcare Conference